These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37139432)
21. Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo. Segerström L; Baryawno N; Sveinbjörnsson B; Wickström M; Elfman L; Kogner P; Johnsen JI Int J Cancer; 2011 Dec; 129(12):2958-65. PubMed ID: 21717457 [TBL] [Abstract][Full Text] [Related]
22. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934 [TBL] [Abstract][Full Text] [Related]
23. Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo. Zhong X; Zhao E; Tang C; Zhang W; Tan J; Dong Z; Ding HF; Cui H Tumour Biol; 2016 Jun; 37(6):7615-23. PubMed ID: 26687647 [TBL] [Abstract][Full Text] [Related]
24. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979 [TBL] [Abstract][Full Text] [Related]
25. In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies. Singh A; Meier-Stephenson V; Jayanthan A; Narendran A Curr Cancer Drug Targets; 2017; 17(6):569-584. PubMed ID: 27875952 [TBL] [Abstract][Full Text] [Related]
26. Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells. Yang Y; Ding L; Zhou Q; Fen L; Cao Y; Sun J; Zhou X; Liu A Cancer Cell Int; 2020; 20():9. PubMed ID: 31920463 [TBL] [Abstract][Full Text] [Related]
27. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Li Z; Jaboin J; Dennis PA; Thiele CJ Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614 [TBL] [Abstract][Full Text] [Related]
28. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells. Naveen CR; Gaikwad S; Agrawal-Rajput R Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712 [TBL] [Abstract][Full Text] [Related]
30. Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Sartelet H; Rougemont AL; Fabre M; Castaing M; Duval M; Fetni R; Michiels S; Beaunoyer M; Vassal G Hum Pathol; 2011 Nov; 42(11):1727-39. PubMed ID: 21641013 [TBL] [Abstract][Full Text] [Related]
31. GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines. Durbas M; Horwacik I; Boratyn E; Kamycka E; Rokita H Int J Oncol; 2015 Sep; 47(3):1143-59. PubMed ID: 26134970 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. Maltese WA; Sheridan KM J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809 [TBL] [Abstract][Full Text] [Related]
33. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines. Shankar SL; Krupski M; Parashar B; Okwuaka C; O'Guin K; Mani S; Shafit-Zagardo B J Neurochem; 2004 Aug; 90(3):702-11. PubMed ID: 15255949 [TBL] [Abstract][Full Text] [Related]
34. NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by miR-183-5p/FOXP1 Via the ERK/AKT Pathway. Pan W; Wu A; Yu H; Yu Q; Zheng B; Yang W; Tian D; Gao Y; Li P Cell Transplant; 2020; 29():963689720943608. PubMed ID: 32693640 [TBL] [Abstract][Full Text] [Related]
35. Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner. Hishiki T; Saito T; Sato Y; Mitsunaga T; Terui E; Matsuura G; Saito E; Shibata R; Mise N; Yokoyama Y; Yoshida H Pediatr Surg Int; 2011 Feb; 27(2):225-30. PubMed ID: 21046121 [TBL] [Abstract][Full Text] [Related]
36. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma. Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984 [TBL] [Abstract][Full Text] [Related]
37. Activation of Akt predicts poor outcome in neuroblastoma. Opel D; Poremba C; Simon T; Debatin KM; Fulda S Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785 [TBL] [Abstract][Full Text] [Related]
38. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of nemorosone in neuroblastoma cells. Díaz-Carballo D; Malak S; Bardenheuer W; Freistuehler M; Reusch HP J Cell Mol Med; 2008 Dec; 12(6B):2598-608. PubMed ID: 18194446 [TBL] [Abstract][Full Text] [Related]
40. Emerging drugs for neuroblastoma. Castel V; Segura V; Berlanga P Expert Opin Emerg Drugs; 2013 Jun; 18(2):155-71. PubMed ID: 23692586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]